Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Week-Long heart patch could Out-Sleuth standard 24-Hour monitor for palpitations

NCT ID NCT07728552

Diagnosis Sponsor: HUINNO Co., Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study tests whether a 7-day adhesive ECG patch (MEMO Patch) can detect more heart rhythm abnormalities than a conventional 24-hour Holter monitor in adults who experience palpitations or dizziness. Participants wear both devices at the same time for the first day, then continue wearing only the patch for six more days. The goal is to see if the longer monitoring period improves detection of arrhythmias like atrial fibrillation or pauses in heart rhythm, while also checking for skin reactions and user satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a 7-day adhesive ECG monitoring patch (MEMO Patch)
What this could lead to
If it works, this could offer a more convenient and longer-lasting way to catch intermittent heart rhythm problems that a standard 24-hour monitor might miss.
What could go wrong
This is a small exploratory study, so results may not apply to everyone. The patch may cause skin irritation or be less comfortable over a full week.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Mar 2020

Finished

Aug 2021

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must meet all of the following criteria: 1. Adults aged 19 years or older who visit the study site during the study period with symptoms such as palpitations or syncope and are considered to require 24-hour ambulatory electrocardiographic monitoring. 2. Able and willing to provide voluntary written informed consent. 3. Able to wear the MEMO Patch™ continuously for 7 days. Exclusion Criteria: * Participants meeting any of the following criteria will be excluded: 1. A self-reported history of an allergic skin reaction to previously used adhesive products. 2. Planned electrical cardioversion, catheter ablation, or surgical treatment for an arrhythmia during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arrhythmia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac cardiac rhythm disease Syncope syncope, familial vasovagal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arrhythmia Palpitations Syncope

Contacts and locations

Locations

  • Seoul National University Bundang Hospital

    Seoul, 13620, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.